Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness and Safety Between Warfarin and Dabigatran Using Real World Claims Data of Japanese Non-valvular Atrial Fibrillation Patients

NCT03254134 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03254134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03254134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness and Safety Between Warfarin and Dabigatran Using Real World Claims Data of Japanese Non-valvular Atrial Fibrillation Patients
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
October 20, 2017
Completion date
November 3, 2017
Enrollment
22,490 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation